
The World Health Organization recommends Directly Observed Therapy (DOT) as the standard treatment for TB, and it has been widely adopted globally. However, DOT places immense pressure on Nurses and TB clinics, which can compromise the success of TB management programs and lead to resource constraints and burnout. Consequently, the effectiveness of tuberculosis care is often compromised, further exacerbating the burden on healthcare systems.

SureAdhere tackles these challenges by providing a comprehensive virtual care solution for TB care providers and clinics. Our platform enables Video Directly Observed Therapy (VDOT) and offers personalized, timely remote treatment support for patients. Giving patients more autonomy and privacy, we also help TB care providers foster long-term treatment adherence and satisfaction, leading to more effective TB programs.
SureAdhere empowers nurses to eliminate routine in-person patient visits, help clinics centralize and streamline DOT administration, and reduce the costs of current DOT programs.

Create comprehensive treatment records at every dose by combining dosing histories, task lists, action logging, and side-effect tracking

Seamlessly engage participants in real-time by combining SMS and secure in-app messaging with integrated live virtual visits

Optimize staff resources by focusing on high-need patients, while increasing observed medication doses and reducing admin costs and manual record-keeping

Integrate seamlessly with EHRs and EMRs to enable centralized data capture, streamline workflows & enhance patient record monitoring
SureAdhere by Dimagi works with over 350 healthcare & clinical programs across the world and is US HIPAA and European GDPR compliant. Additionally, the platform meets the 21 CFR-Part 11 compliance requirements.
SureAdhere’s reliability is proven through rigorous studies and real-world application, ensuring that patients receive the highest standard of care.



